Geneva, October 31, 2012 Eduardo Pisani, IFPMA Director General
Read moreRead more
Nov 5, 2012 Mr. Innovation takes you on a quick, under-3-minute journey to discover his beginnings, his major achievements in health and other fields, and major challenges ahead. How has innovation made strides in global health? Can innovation win the fight against life-threatening diseases? Watch and find out.
Read moreGeneva, October 31, 2012 Dr. John C. Lechleiter, Chairman, President and CEO, Eli Lilly and Company
Read more• Conference draws more than 200 public and private sector health leaders to discuss role and contributions of biopharmaceutical innovation • Three corporate leaders outline industry’s commitment and call for a shared commitment to improving global health Today a biennial health conference brings together public and private sector leaders for an open dialogue on how...
Read moreCommissioned by IFPMA, the study identifies tailored, consistent long-term government policies as key factors to foster biopharmaceutical innovation An independent study on biopharmaceutical innovation in middle-income countries was released today at the 26 th IFPMA Assembly in Geneva. The report analyzed key national political and economic factors that foster biopharmaceutical innovation. The study, Policies that...
Read moreDr John Lechleiter, Chairman, President and CEO, Eli Lilly and Company; Mr Masafumi Nogimori,Chairman of the Board, Astellas Pharma Inc.; Dr. Stefan Oschmann, Merck Executive Board Member and Chief Executive Officer of Merck Serono statement written to coincide with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) biennial health conference under the theme “Innovating...
Read moreSir George Alleyne Director, Pan American Sanitary Bureau (PASB)
Read morePublication contains recommendations for governments and other stakeholders to address MNDs Research in this disease area is complex, time-consuming, and needs to be incentivized Launch coincides with World Mental Health Day to raise awareness on the burden of mental and neurological disorders on society Today the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) released...
Read moreWorkplace wellness programs can be effective win-wins for employees and companies Report shows that pharmaceutical companies drive initiatives that boost health through disease prevention and management, reaching over 1.1 million employees worldwide IFPMA released Health by the Numbers, a report detailing the 2011 results of the IFPMA Wellness Survey. Through this assessment, IFPMA sought...
Read moreDirectory highlights commitment of the research-based pharmaceutical industry and partners to improve health in the developing world through 220 partnerships operating in more than 160 countries Launch coincides with the release of new BSR review evaluating these partnerships and providing recommendations for the future The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) published the...
Read more